COGHILL CLINT D

Director Clint Coghill sold 1,000,000 shares (28.5% of holdings) for $6,454,821.89 across three transactions at $6.31–$6.66.

Director Clint Coghill executed 3 separate sales totaling 1,000,000 shares for $6,454,821.89, reducing his stake from 3,504,347 shares to 2,504,347 shares—a 28.5% reduction of his pre-transaction holdings. The sales occurred at prices ($6.31–$6.66) near the 52-week high of $6.54, and the blended average price of $6.45 is only 4.4% below the current stock price of $6.18 and 1.4% below the 52-week high, suggesting the sales were executed at elevated levels. Notably, his prior 5 purchases at AMPY were all well-timed at the 90-day mark (positive returns post-purchase), but this large discretionary sale warrants scrutiny given the company's deteriorating fundamentals: annual revenue declined 10.6% year-over-year, net income was negative at -$20,966,000.00, and the stock currently trades at a P/E of 77.25. The timing and magnitude of the sale—eliminating nearly one-third of holdings at valuation peaks—contrasts with his prior accumulation pattern and suggests a material reduction in exposure to Amplify Energy.

AMPY director Coghill purchases 350,000 shares for $1.3M across 3 days at $3.82–$3.89 avg; holdings rise 11.1% to 3.50M shares

Clint D Coghill, a director of Amplify Energy, executed 3 separate open-market purchases totaling 350,000 shares for $1,335,988.85 between August 12–14, 2025, at prices ranging from $3.69 to $3.89 (blended average $3.82). This transaction increases his post-transaction holdings to 3,504,347 shares from 3,154,347 shares—a net addition of 350,000 shares (+11.1% versus pre-transaction holdings). The current price of $3.95 sits 45.4% below the 52-week high of $7.23 but 22.3% above the 30-day prior level and 35.7% above the 90-day prior level. His prior 4 purchases at AMPY since June 2025 show a -11.2% 30-day return on the June 20 buy, with 3 other purchases still awaiting 90-day outcome measurements. Cross-ticker, his track record on 4 prior buys averages a -5.9% 30-day return. The company trades at a P/E of 10.13 with $68.4M quarterly revenue, $6.4M net income, and an annual revenue decline of 4.2%. The timing of this acquisition—a substantial 11.1% increase in holdings over three consecutive trading days in a stock down 45.4% from its 52-week high—falls against a backdrop of prior buys at this ticker showing underwater 30-day returns and a cross-ticker pattern of negative average returns within 30 days of purchase.

Director Coghill buys 150,000 AMPY shares at $3.67; stock down 59.9% from 52-week high but up 18.2% in 30 days.

Clint D Coghill, a Director at Amplify Energy Corp., purchased 150,000 shares at $3.67 on 2025-06-20, increasing his holdings from 3,004,347 to 3,154,347 shares. The transaction occurred as the stock trades at $3.19, substantially below its 52-week high of $7.96 but in the context of a recent 18.2% 30-day gain. Prior same-ticker buys by Coghill on 2025-06-04, 2025-06-05, and 2025-06-06 remain too recent to assess outcomes. The underlying business faces headwinds: annual revenue contracted 4.2% year-over-year, with the latest quarter showing a $5.9M net loss against $72.0M in revenue. This is a modest-scale purchase by the director relative to his substantial existing position and occurs in a security with sharply depressed valuation, warranting observation of whether this pattern continues or reverses.

Director Coghill buys 304,000 shares over 3 days at avg $3.28; holdings rise 11.3% to 3.00M shares

Director Clint D Coghill purchased 304,000 shares in three separate transactions on 2025-06-04 through 2025-06-05, paying $997,190.00 at prices ranging from $3.26 to $3.40—each within 1-3 cents of the current price of $3.25. This purchase increased his holdings by 11.3%, from 2.70M shares to 3.00M shares. The stock is currently trading 59.2% below its 52-week high of $7.96, despite a 20.8% gain over the past 30 days. Against this backdrop, the company is generating negative net income of $-5.9M on quarterly revenue of $72.0M, with annual revenue declining 4.2% year-over-year. The multi-day accumulation at depressed valuations warrants monitoring of whether this represents conviction in a turnaround or a test of floor-building support.